ArticleJournal of fungi (Basel, Switzerland)2026
New Cyclohexenols and Benzopyran Derivatives from Fungus
Ningning Shi, Junling Guo, Zhen Zhang, Feng Jing, Shuoyu Zhao, Yan Fu, Xinhua Lu, Yucheng Gu, Binliang Tong, Manli Zhang
Abstract read
In one paragraphArticle in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Ningning ShiHebei Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.
Junling GuoHebei Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.
Zhen ZhangHebei Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.
Feng JingHebei Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.
Shuoyu ZhaoHebei Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.
Yan FuCore Facilities and Centers, Hebei Medical University, Shijiazhuang 050017, China.
Xinhua LuNew Drug Research & Development Center of North China Pharmaceutical Group Corporation, Shijiazhuang 052165, China.
Yucheng GuSyngenta Jealott's Hill International Reasearch Centre, Bracknell RG12 6EY, Berkshire, UK.ORCID 0000-0002-6400-6167 Binliang TongDepartment of Pharmacy, The First Affiliated Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Manli ZhangHebei Key Laboratory of Innovative Drug Development and Evaluation, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.ORCID 0000-0002-2041-5022 Funding
Hebei Provincial Department of Education QN2026533Syngenta (United Kingdom) 2020-Hebei Medical University-Syngenta
6 · The paper itselfAbstract
A chemical study of the fungus
Indexed as
Aspergillus fumigatusbenzopyran derivativescyclohexenolsinhibitory activity of protein tyrosine phosphatases (PTPs)
Identifiers
PMID42506268
PMCPMC13413059
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390